Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Quantum-Si announced it will participate in the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14-16, 2026.
CEO Jeff Hawkins and CFO Jeff Keyes will host one-on-one meetings on September 15, with Hawkins also scheduled to deliver a fireside chat at 1:30 PM ET that day.
A live and archived webcast of the fireside chat will be accessible through the Investors section of the Quantum-Si website.